Condition
Hormone Receptor Positive, HER2 Negative Breast Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hormone Receptor Positive, HER2 Negative Breast Cancer clinical trials that are recruiting, at sites in 2 countries (most in Italy (1), United States (1)). 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 2Countries
All recruiting trials (2)
-
Short-Term Low-Protein Diet Around Chemotherapy for ER+/HER2- Breast Cancer
A short-term, reduced-protein diet is being tested around the first four cycles of neoadjuvant chemotherapy to see if patients can follow it and stay adherent.
-
Predicting outcomes for advanced breast cancer patients treated with CDK4/6 inhibitors and endocrine therapy
This study is trying to see how well different CDK4/6 inhibitors combined with hormone therapy work for people with advanced breast cancer and how safe they are.
Related topics
Quick answers
How many Hormone Receptor Positive, HER2 Negative Breast Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.